Loading clinical trials...
Loading clinical trials...
The PREPPeD Study: "PREdelivery Placental Biomarkers- Pregnancy and Delivery Outcome"
The PREPPeD study proposes that predelivery placenta-derived maternal circulating biomarkers reflect placental health, capacity and ageing, and can help predict onset and complications of delivery both in complicated pregnancies as well as in clinically uncomplicated term/post-term pregnancies.
The main aim of the PREPPeD study is to explore whether placental health, evaluated by maternal blood biomarkers in late pregnancy, correlates with delivery outcomes in both healthy and complicated pregnancies.
Age
All ages
Sex
FEMALE
Healthy Volunteers
Yes
Oslo University Hospital
Oslo, Norway
Start Date
September 15, 2016
Primary Completion Date
September 1, 2022
Completion Date
September 1, 2022
Last Updated
December 19, 2020
1,000
ESTIMATED participants
Blood sampling
OTHER
Lead Sponsor
Oslo University Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions